Home
Conditions
Hemostatic Disorders

Clinical trial condition

Hemostatic Disorders

Explore clinical trials studying Hemostatic Disorders. Study availability and eligibility vary by location and protocol.

3,075 public trials 581 recruiting studies

Refine in advanced search Browse all conditions

Hemostatic Disorders trial results

Completed

Study of Daratumumab in Combination With Dexamethasone in Resistant or Refractory Multiple Myeloma

NCT02626481

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: AZ ST Jan hematology department Bruges, Belgium

Hematologie Laarbeeklaan Brussels, Belgium

Jules Bordet Institute Brussels, Belgium

CHU Dinant Godinne | UCL Namur asbl Yvoir, Belgium

View all 41 locations

View Trial Details

Completed

Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients

NCT00574652

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Cryoglobulinemia, +13 more
Locations: Hôpital de la Pitié Paris, France

View Trial Details

Completed

Geriatric Optimization Plan to Improve Survival in Older Adult Allogeneic Hematopoietic Cell Transplant Candidates, OTIS Study

NCT05972577

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Anemia, +49 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Completed

Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation

NCT01067287

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Rambam Medical Center Haifa, Israel

View Trial Details

Completed

Vorinostat,Lenalinomide and Dexamethasone in Multiple Myeloma Refractory to Previous Lenalinomide Containing Regimens

NCT01502085

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

A Phase II Study of Carfilzomib in Relapsed Waldenström's Macroglobulinemia (WM) IST-CAR-531

NCT01813227

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

Escalating Doses of Thalidomide in Conjunction With Bortezomib and HIgh Dose Melphalan for BSCT

NCT01242267

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

NCT01315132

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +20 more
Locations: Thomas Jefferson University Philadelphia, Pennsylvania, United States

View Trial Details

Completed

ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

NCT03441958

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond Montreal, Quebec, Canada

View Trial Details

Completed

Daratumumab in Combination With Lenalidomide and Dexamethasone in Relapsed and Relapsed-refractory Multiple Myeloma

NCT01615029

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +16 more
Locations: Boston, Massachusetts, United States

Copenhagen Ø, Denmark

Vejle, Denmark

Lille, France

View Trial Details

Hemostatic Disorders

Hemostatic Disorders trial results

Related conditions